Danaher Corporation DHR-PA Stock
Danaher Corporation Price Chart
Danaher Corporation DHR-PA Financial and Trading Overview
Danaher Corporation stock price | 1841.01 USD |
Previous Close | 1891.77 USD |
Open | 1872 USD |
Bid | 0 USD x 1300 |
Ask | 0 USD x 1800 |
Day's Range | 1841.01 - 1888.78 USD |
52 Week Range | 1654.64 - 2230.24 USD |
Volume | 160.76K USD |
Avg. Volume | 24.46K USD |
Market Cap | 169.33B USD |
Beta (5Y Monthly) | 0.776082 |
PE Ratio (TTM) | 233.57143 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | 47.5 (2.60%) |
Ex-Dividend Date | March 30, 2022 |
1y Target Est | N/A |
DHR-PA Valuation Measures
Enterprise Value | 1.29T USD |
Trailing P/E | 233.57143 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.7492857 |
Price/Book (mrq) | 32.73547 |
Enterprise Value/Revenue | 43.738 |
Enterprise Value/EBITDA | 124.634 |
Trading Information
Danaher Corporation Stock Price History
Beta (5Y Monthly) | 0.776082 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 2230.24 USD |
52 Week Low | 1654.64 USD |
50-Day Moving Average | 1865.98 USD |
200-Day Moving Average | 2009.51 USD |
DHR-PA Share Statistics
Avg. Volume (3 month) | 24.46K USD |
Avg. Daily Volume (10-Days) | 43.27K USD |
Shares Outstanding | 700.9M |
Float | 649.34M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 85.72% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.81 |
Trailing Annual Dividend Yield | 0.042% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | December 31, 2021 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 21.84% |
Operating Margin (ttm) | 27.73% |
Gross Margin | 61.30% |
EBITDA Margin | 35.09% |
Management Effectiveness
Return on Assets (ttm) | 6.40% |
Return on Equity (ttm) | 14.94% |
Income Statement
Revenue (ttm) | 29.45B USD |
Revenue Per Share (ttm) | 41.22 USD |
Quarterly Revenue Growth (yoy) | 20.50% |
Gross Profit (ttm) | 18.06B USD |
EBITDA | 10.34B USD |
Net Income Avi to Common (ttm) | 6.18B USD |
Diluted EPS (ttm) | 7.882 |
Quarterly Earnings Growth (yoy) | 44.10% |
Balance Sheet
Total Cash (mrq) | 2.59B USD |
Total Cash Per Share (mrq) | 3.62 USD |
Total Debt (mrq) | 23.27B USD |
Total Debt/Equity (mrq) | 51.51 USD |
Current Ratio (mrq) | 1.431 |
Book Value Per Share (mrq) | 56.239 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.36B USD |
Levered Free Cash Flow (ttm) | 5.48B USD |
Profile of Danaher Corporation
Country | United States |
State | DC |
City | Washington |
Address | 2200 Pennsylvania Avenue, NW |
ZIP | 20037-1701 |
Phone | 202 828 0850 |
Website | https://www.danaher.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 78000 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Q&A For Danaher Corporation Stock
What is a current DHR-PA stock price?
Danaher Corporation DHR-PA stock price today per share is 1841.01 USD.
How to purchase Danaher Corporation stock?
You can buy DHR-PA shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Danaher Corporation?
The stock symbol or ticker of Danaher Corporation is DHR-PA.
Which industry does the Danaher Corporation company belong to?
The Danaher Corporation industry is Diagnostics & Research.
How many shares does Danaher Corporation have in circulation?
The max supply of Danaher Corporation shares is 0.
What is Danaher Corporation Price to Earnings Ratio (PE Ratio)?
Danaher Corporation PE Ratio is 0.00000000 now.
What was Danaher Corporation earnings per share over the trailing 12 months (TTM)?
Danaher Corporation EPS is 0 USD over the trailing 12 months.
Which sector does the Danaher Corporation company belong to?
The Danaher Corporation sector is Healthcare.